Inhale-3 Investment Portfolios

Pharmaceuticals
INHALE-3 Study Highlights the Efficacy of Inhaled Insulin Over Usual Care for Type 1 Diabetes Jun 23, 2024
Biopharmaceuticals
Initial Results of INHALE-3 Study: Afrezza® vs. Conventional Insulin Delivery Mar 12, 2024